Back

Comprehensive analysis of desmosomal proteins remodeling identifies DSC2 as a potential biomarker for arrhythmogenic cardiomyopathy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk prediction for ventricular arrhythmias: new tools for improved precision Arrhythmogenic Right Ventricular Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jie Ren

Fuwai Hospital, CAMS and PUMC, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Increased health care utilization prior to sudden cardiac death in the general population
Doctor T. Skjelbred (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and machine learning-based prediction of acquired Long QT Syndrome among hospitalized patients
Doctor J. Luo (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Right ventricular dysfunction: an overlooked predictor of sudden cardiac death and arrhythmic events: a meta-analysis
Doctor T. Chiba (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Electrocardiogram-based QRS analysis predicts ventricular arrhythmias in patients after cardiac electronic device implantation: a prospective study
Doctor B. Fu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Long-term relative survival in patients with premature ventricular complexes but structurally normal hearts
Mr R. Bouleau (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk prediction for ventricular arrhythmias: new tools for improved precision
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Unraveling the enigma of DSG2 p.(N266S): a culprit in arrhythmogenic cardiomyopathy
thumbnail
Congress Presentation
The impact of desmosomal mutations on clinical features in arrhythmogenic cardiomyopathy: towards tailored arrhythmic risk stratification
thumbnail
Congress Presentation
Clinical value of anti-DSG2 antibodies in arrhythmogenic right ventricular cardiomyopathy: a real-life experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources